Semaglutide biosimilar is under clinical development by Leto Laboratories and currently in Phase II for Diabetes.

ENB-105 is under development for the treatment of inflammatory bowel disease and immune checkpoint inhibitor colitis (ICI-Colitis). It is being developed based on eSTEM systems biology platform.

President-elect Donald Trump’s threat to eliminate tax credits for electric vehicles likely gave plug-in cars a much-needed boost after a disappointing year, part of a broader surge in auto sales ...

As inflation continues to squeeze household budgets across the Asia-Pacific (APAC) region, consumers are increasingly turning ...

"Arcos Dorados renews master franchise agreement with McDonald’s" was originally created and published by Verdict Food ...

One prominent FDA-watcher said he sees no new regulations coming down in a new Trump administration, but he wondered if this was an opportunity to further reorganize food safety, possibly with a ...

Overall EV sales gained 12%, pushing the full-year total to a record 1.3 million, according to forecasts from researcher Cox Automotive.

Immuno-oncology (IO) drugs or cancer therapeutics represent one of the most promising areas of medical innovation in the next five years, according to a report on Friday. The report by GlobalData, a ...

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

The “Instrument and Electrical Reliability Engineering (I&E RE)” position in Chevron’s ENGINE Centre (located in Bengaluru, ...

Prasanth Katam, an insurance analyst at GlobalData, noted that South Korea’s economy grew by only 1.4% in 2023, which ...

The surge in tunnelling and anchoring machinery patents is driven by the need for technological innovation to improve mining processes.